文献速递中医内科中药与中成药合理使用

中药调控脑缺血再灌注损伤线粒体功能障碍

Traditional Chinese Medicine regulate mitochondrial dysfunction in cerebral ischemia-reperfusion injury.
PubMed 文献 · J Ethnopharmacol · 2025-10-30

本文综述中药成分、提取物、单味药、复方及中成药通过调控线粒体氧化应激、炎症反应、金属离子失衡及线粒体质量控制等途径干预脑缺血再灌注损伤(CIRI)线粒体功能障碍的机制,为CIRI治疗提供新思路,并指出需进一步评估中药潜在副作用及临床剂量与个体差异。

要点

  • 线粒体功能障碍是CIRI的关键因素,中药可多靶点调控其发生发展。
  • 中药通过抗氧化应激、抗炎、调节金属离子及线粒体质量控制发挥作用。
  • 临床使用需关注中药潜在副作用、剂量控制和个体差异。

核心结论

  • 线粒体功能障碍是CIRI的关键因素,中药在其防治中发挥积极作用并提供新希望。
  • 需进一步研究评估中药潜在副作用,临床密切监测剂量控制和个体差异。
  • 需阐明细胞内线粒体/细胞器的复杂网络调控及靶点位置。

研究设计与样本

  • 综述类:在PubMed、Web of Science、CNKI和万方等数据库进行广泛文献检索。
  • 检索关键词涉及CIRI、线粒体功能障碍、天然产物、分子机制等,植物名称经Medicinal Plant Names Services(MPNS)验证。

主要发现

  • 中药复方和单体化合物可通过调控线粒体氧化应激、炎症反应、金属离子失衡和线粒体质量控制有效控制CIRI的发生和进展。

临床怎么用

  • 临床可基于药物剂量和个体差异进行精准治疗,中药在CIRI治疗中应用前景良好。
  • 使用中药时需关注潜在副作用、剂量控制和个体差异。

局限性

  • 需进一步研究评估中药潜在副作用。
  • 临床使用需密切监测剂量控制和个体差异。
  • 需阐明线粒体/细胞器复杂网络调控及靶点位置。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Ischemic stroke is a major global cause of high mortality. Cerebral ischemia-reperfusion injury (CIRI) involves pathophysiological events post-blood flow restoration, promoting pathological signaling, disrupting brain metabolism, and worsening damage. Surgical interventions carry risks. Chinese herbal medicines, derived from natural sources, multi-component, multi-target and comprehensive regulation. In clinical, precise treatment is administered based on drug dosage and individual variations, demonstrating promising application prospects in the therapy of CIRI. AIM OF THE STUDY: This article reviews mechanisms by which TCM components, extracts, herbs, TCM formulas, and patent medicines act on mitochondrial dysfunction induced by CIRI. These mechanisms include mitochondrial oxidative stress, inflammatory responses, metal ion dysregulation, and mitochondrial quality control, providing new insights for CIRI treatment. MATERIALS AND METHODS: An extensive literature search was conducted across databases like PubMed, Web of Science, CNKI, and Wanfang, using keywords related to CIRI, mitochondrial dysfunction, natural products, molecular mechanisms, And TCM Plant names were verified using the Medicinal Plant Names Services. (MPNS,http://mpns.kew.org). RESULTS: TCM formulas and monomeric compounds can effectively control the occurrence and progression of CIRI by regulating mitochondrial dysfunction, such as mitochondrial oxidative stress, inflammatory responses, metal ion imbalance, and mitochondrial quality control. CONCLUSION: Mitochondrial dysfunction is a key factor in CIRI. TCM play an active role in its prevention and treatment, offering new hope. However, further research is needed to assess TCM's potential side effects and closely monitor dosage control and individual variations in clinical use. Elucidate the complex network regulation and target sites of mitochondria/organelles within cells.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Zhao N, Zhu D, Wang Y, et al. Traditional Chinese Medicine regulate mitochondrial dysfunction in cerebral ischemia-reperfusion injury. J Ethnopharmacol. 2025. PMID: 41176136. doi:10.1016/j.jep.2025.120832

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。